Greece

Innovators/Entrepreneurs

Date of the expedition

From 19/10/2023 to 19/04/2024

Selected Track

Open Ideas

Project title

Magos haptic solution

Host Organization

Mason Enterprise Center Fairfax

Media

Biography

Greg Agriopoulos, Founder & CEO at Quanta & Qualia (doing business as Magos)

  • MBA in Technological Innovation Management
  • MSc in embedded systems, signal processing and wireless communications
  • BSc in Electrical Engineering

Visionary of technology with high impact goals.

Tech enthusiast with great systems engineering and deep technical understanding skills.

Expert in wearable hardware for advanced Human Computer/Robot Interaction sector focused on VR training and simulation (Healthcare, Aerospace, Industry 4.0)

Unique blend of technical and business skills with over 15 years’ experience in:

  • Entrepreneurship & Deep tech Innovation,
  • Strategy & Sales,
  • Business Development,
  • Leadership & Team management,
  • Contract management,
  • Product-Market fit,
  • Funding & Financial Analysis-Projections,
  • Deep technical understanding & Systems engineering.

Project Summary

Analyse the product market fit of Magos haptic solution in medical, academic, industrial sectors.

Explore George Mason University and other stakeholders (universities, corporates, Venture capitals) in Virginia.

Explore the USA East Coast (Boston, New York, Philadelphia) ecosystem for potential customers (universities, medication simulation labs) and funding organizations (Angel groups, Venture Capitals)

Key Result

Performed several interviews and demos to both GMU labs and the Virginia ecosystem.

Finalized the I-Corps program and fine-tuned the existing Business model canvas.

Optimized the product/market fit.

Participated in events and interacted with key stakeholders (investors, large companies, collaboration partners)

Impact of the Fellowship

  • Received feedback from the solution demos and build a roadmap for improvements of the solution.
  • Performed several demos
  • Analysed the product/market fit in medical, academic, industrial 5.0 sectors
  • Strengthening research collaboration with the US
  • Strengthening innovation collaboration with the US
  • Accelerated contacts/engagements with investors, VCs
  • Accelerated business partnerships for developed technologies/solutions
  • Fundraising (proposals to public organisations) – indicate, in the US/Canada or Europe
  • Expanding collaboration within the NGI community
  • Conference attendance with paper/poster/ proceedings